Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis

Liusheng Wu(Anhui Medical University), Xiaoqiang Li(Chinese Academy of Sciences), Pengcheng Xu(Peking University Shenzhen Hospital), Jun Yan(Fujian Medical University), Yanfeng Zhong(Peking University Shenzhen Hospital), Jixian Liu(Dongguan University of Technology), Xin Ruan(Peking University Shenzhen Hospital), Dingwang Wu(Peking University Shenzhen Hospital)
Biomedicines
September 10, 2022
10.3390/biomedicines10092248
Cited by 121

Related Papers

Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research
|Anti-Cancer Drugs|2022|120
Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19
|Aging|2021|115
Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD)
|Biomedicines|2023|112
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
|Vaccines|2024|106
Research progress of 3D-bioprinted functional pancreas and in vitro tumor models
|International Journal of Bioprinting|2024|71